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Domestic canines are regarded as natural sentinels
 
for the transmission of vector-
borne pathogens since infection in an owner’s dog suggests the presence of the vector in 
or around the household. In collaboration with the University of Kentucky’s Veterinary 
Diagnostic Lab in Lexington, Kentucky, we have investigated the prevalence of 
Trypanosoma cruzi (the causative agent of Chagas disease) in canines from central and 
eastern Kentucky via a serological test, polymerase chain reaction (PCR), and DNA 
sequencing. In addition, Canine SNAP 4Dx plus tests (Idexx Laboratories, Inc.) were 
used to determine the prevalence of four other vector-borne pathogens: Ehrlichia 
canis/ewingii, Borrelia burgdorferi, Anaplasma phagocytophilum/platys, or Dirofilaria 
immitis in the dogs. Results to date reveal a surprisingly high sero-prevalence of 10.23% 
for T. cruzi. Two positive samples (2.27%) were confirmed using the polymerase chain 
reaction and one resulted in a known T. cruzi sequence. In addition, results of the SNAP 
4DX plus tests showed a prevalence of 5.68% for Ehrlichia canis/ewingii (the causative 
agent of ehrlichiosis) and 6.82% for B. burgdorferi (the Lyme disease spirochete). We 
believe that further studies are urgently needed to fully evaluate the role that canines 
might be playing as reservoir hosts for these as well as other vector borne diseases in 
Kentucky.  
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Carlos Chagas, a Brazilian physician, was the first to discover Trypanosoma cruzi 
(Chagas, 1909) while studying parasitic diseases in South America. Chagas observed 
symptoms in patients that did not match any known disease. In his life, Chagas was able 
to determine the clinical symptoms of infection, the epidemiology and life cycle of the 
parasite within the vector and human host as well as other definitive hosts (Clayton, 
2010). In honor of the extensive work Chagas put into the disease, it is now commonly 
known as Chagas disease. It is also known as American trypanosomiasis due to the fact 
that the etiological agent is a trypanosome that is endemic in North America, Central 
America and South America.  
 
Chagas disease in the United States: 
Trypanosoma cruzi, the etiological agent of Chagas disease, is endemic to areas of 
Mexico, Central America, and South America. However, recent studies have shown that 
the parasite life cycle is also well established within the United States. As of 2009, the 
estimated number of people with Trypanosoma cruzi infection within the United States 
was 300,167 individuals (Bern et al., 2009). The majority of these cases occur in 
individuals who have emigrated from Chagas endemic areas.  
2 
 
It is well known that canines can serve as crucial reservoir hosts in Latin America 
(Gurtler et al., 1991). However, the role that dogs may be playing in the epidemiology of 
Chagas disease in the United States is not well known (Beard et al., 2003). Trypanosoma 
cruzi infection has been documented in the canine populations of Virginia, Oklahoma, 
Tennessee, Louisiana, and Texas (Bradley et al., 2000; Burkholder et al., 1980; Kjos et 
al., 2008; Rowland et al., 2010; Rosypal et al., 2010; Shadomy et al., 1980; Snider et al., 
1980; Williams et al., 1977; Meurs et al., 1998). Trypanosoma cruzi infection in the 
domestic canine population implies that the vector is also likely present in the vicinity of 
the human household. 
Within the southeastern United States, there is evidence to support the presence of 
a sylvatic cycle that involves the transmission of the parasite between Reduviid bugs and 
wildlife reservoir hosts (Rosypal et al, 2007). There have been studies that show that wild 
canids are also contracting Chagas disease. This is evident in the Rosypal et al., (2007) 
study where 2 out of 26 gray foxes (8%) were T. cruzi positive out of South Carolina.  
This shows that the cycle is perpetuated in the environment where canines are potentially 
exposed.  
It is assumed that canines are obtaining the infection by chewing the Reduviid 
bug that is infected with T. cruzi. When infection is acquired, there is the possibility for a 
dog to develop both acute and chronic Chagas disease. Mortality in the acute phase is 
more common in very young dogs due to their inability to fight off the parasite. This 
acute disease includes possible cardiomegaly and/or cardiac arrhythmias depending on 
the strain of T. cruzi (Guedes et al., 2007, Kjos et al., 2008). Chronic disease commonly 
manifests as heart disease in older canines which will ultimately lead to the death of the 
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dog (Barr et al., 1991, Kjos et al., 2008). These symptoms are very similar to those that 
occur within human populations. Unfortunately, at this time there are no approved 
medications that veterinarians can use to combat this disease in canines. 
 
Life Cycle of Trypanosoma cruzi:  
 Triatomine bugs in the insect family Reduviidae serve as intermediate hosts in the 
life cycle of T. cruzi. Within the southeast this is predominately Triatoma sanguisuga 
(Figure 1.1). The triatomine bug feeds on a potential host, typically a mammal, and 
defecates on the skin as it takes its blood meal. The trypomastigote stages present in the 
bug’s feces are introduced into the bite wound or enter via the mucous membrane of the 
eyes, nose or mouth. Trypomastigotes enter host cells at the site of entry, and then rapidly 
transform into amastigote stages. The amastigote stages then replicate through several 
rounds of binary fission and then transform once again into trypomastigotes. 
Trypomastigote stages erupt from the cells and disseminate to other cells and tissues. 
Trypomastigotes circulating in the blood are also infective for the intermediate host, the 
triatomine bug. The triatomine ingests the trypomastigotes along with the blood meal. 
Within the mid-gut of the triatomine, the parasites transition into the epimastigote stage. 
During this stage the epimastigotes proliferate in the gut before once again transforming 
back to the trypomastigote stage in the hind gut. The trypomastigote stage is then 
released when the triatomine bug defecates while consuming a blood meal. (CDC, 






Figure 1.1: Triatoma Sanguisuga (retrieved from CDC.gov) 
 
 





Other Vector Transmitted Diseases 
There have been surprisingly few published studies that have investigated the 
prevalence of tick-borne and other vector-borne pathogens within the canine population 
within the state of Kentucky. These vector-borne pathogens include Borrelia burgdorferi, 
Ehrlichia canis/ewingii, Anaplasma phagocytophilum/platys, and Dirofilaria immitis. 
Borrelia burgdorferi, the causative agent of Lyme disease (Burgdorfer et al., 1982) and 
Ehrlichia canis/ewingii, the causative agents of ehrlichiosis, are present in both human 
and canine populations. Similar to T. cruzi, canines also serve as a reservoir host for these 
diseases that are also communicable to human (Shaw et al., 2001).  
The prevalence of Borrelia burgdorferi in Kentucky, according to a 2011 study of 
287 ticks, is low, with only one tick (0.4%) confirmed to be positive for Borrelia 
lonestari. This bacterial species causes a variant of Lyme disease known as southern tick 
associated rash illness (STARI) (Fritzen et al., 2011). None of the ticks were carrying 
Borrelia burgdorferi in that study. The prevalence of Ehrlichia ewingii, which was also 
reported in this study, was 4 out of the 287 ticks (1.4%). In another study published in 
2012, the prevalence of Ehrlichia ewingii in Kentucky was determined to be 3 out of 16 
dogs and 1 out of 16 dogs for Ehrlichia canis (Beall et al., 2012). 
Anaplasma phagocytophilum/platys, the causative agent of anaplasmosis in both 
canines and humans, leads to the infection of the host’s neutrophils and neutrophil 
precursors (Sarkar et al., 2007). In an unpublished study from our lab, the prevalence of 
Anaplasma phagocytophilum/platys was 2 out of 361 domestic canines (0.53%). This 
study was conducted on dogs from the western half of the state.  
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Dirofilaria immitis, the causative agent of canine heartworm, is transmitted 
through a mosquito vector. In the same unpublished study from our laboratory, the 
prevalence of Dirofilaria immitis in the western region of the state was determined to be 







MATERIALS AND METHODS 
 
 
Canine sera: Serum or blood samples from domestic canines were obtained from 
the University of Kentucky Veterinary Diagnostic lab and were transported back to 
Western Kentucky University under refrigerated conditions. Upon arrival, a 250 micro-
liter aliquot was removed from each sample, placed into a sterile microfuge tube, and 
stored at a temperature of -20˚C. The collection vials containing the remaining sera or 
blood samples were stored at 4˚C until use. Along with the serum samples, we recorded 
the county of the reporting veterinarian, as well as the sex, age and breed of the canine. 
 
Chagas dipstick chromatography test: Twenty micro-liters of sample canine 
serum were applied to the dipstick’s sample pad and the end of the dipstick was placed 
into one well of a 96-well, micro-liter plate.  Three drops of chase buffer were then added 
to the well. Additional buffer was added after one minute if the buffer had not yet 
reached the test line. This additional buffer was typically one drop. After 10 minutes, the 
results were read.  The presence of a positive control line indicated that the test was 
functioning properly, and the presence of a second test line was indicative of a positive 




Figure 2.1: INBIOS dipstick example 
 
 
SNAP 4Dx Plus Test (IDEXX):  After being allowed to equilibrate to room 
temperature for 30 minutes, 3 drops of canine serum were added to a clean microfuge 
tube. Four drops of the conjugate buffer were then added and the tube was inverted 
several times to thoroughly mix the contents.  The contents of the tube were then applied 
to the sample well. Once the solvent front reached the activation window, the activator 
pad was snapped down.  Results were read after 8 minutes.  The presence of a positive 
control dot indicated that the test was functioning properly, and the presence of other dots 
in specific locations indicated positive results for Ehrlichia canis/ewingii, B. burgdorferi, 
Anaplasma phagocytophilum/platys, or Dirofilaria immitis respectively. (See Figure 2.2) 
Some of the names are in red because they are the additional strains of the disease added 
to the Snap test that distinguished between the Snap 4DX and the Snap 4DX Plus. 
 







DNA Isolation: Genomic DNA was isolated from 200 micro-liters of serum or 
whole blood from each canine that gave a positive result on the Canine Chagas Dipstick 
test. QIAamp DNA blood mini kits (Qiagen) were used for DNA isolation. DNA 
concentrations were determined using a Nanodrop 2000 Spectrophotometer (Thermo 
Scientific), and the DNA samples were stored at -20
o
C until use. 
 
Polymerase Chain Reaction (PCR): PCR amplification was performed on 
selected positive and negative DNA samples, using the TCZ1 and TCZ2 primer pair. The 
TCZ1 and TCZ2 primers were designed to amplify 188 base pairs (bp) of a 195-bp 
repetitive nuclear sequence of T. cruzi (Moser et al., 1989). The TCZ1 and TCZ2 primers 
represent the following genomic sequences: TCZ1 (5’-CGA GCT CTT GCC CAC ACG 
GGT GCT 3’) and TCZ2 (5’-CCT CCA AGC AGC GGA TAG TTC AGG 3’). Each 
reaction mixture consisted of 20 micro-liters of the Master Mix, 1 micro-liter of the 
TCZ1 primer, 1 micro-liter of the TCZ2 primer, 3 micro-liters of nanopure water, and 25 
micro-liters of the canine template DNA. A negative control containing sterile nanopure 
water in place of template DNA and a positive control sample of T. cruzi genomic DNA 
were included with each analysis. Reaction mixtures were placed into an automated DNA 








Figure 2.3. Thermocycler Protocol used for TCZ1 and TCZ2 primers. 
Thermocycler program for PCR amplification using the TCZ1 and TCZ2 primers. 
 Temperature (°C) Time # of cycles 
Initial Denature  94 2 min 1 
Denature  94 1 min 30 
Annealing  64.5 30 sec  
Extension  72 15 sec  
Final extension  72 5 min 1 
Hold  4 Indefinite 1 
 
Gel Electrophoresis: PCR products, as well as two 1-kb DNA ladders, were 
loaded onto 2% agarose gels (containing GelRed) and subjected to electrophoresis at 
100V for 1 hour. Gels were then taken to the Western Kentucky University 
Biotechnology Center where images were captured using a Fluor Chem HD2 (Alpha 
Innotech). These images were then saved permanently for later access. 
 
DNA Sequence Analysis: A Big Dye Terminator v3.1 (Applied Biosystems) 
sequencing reaction was performed on a subset of DNA samples determined to be 
positive by PCR. Unincorporated dye terminators were removed from PCR amplification 
products using a DyeX 2.0 Spin Kit (Qiagen), and samples were subjected to DNA 
sequence analysis using an ABI 3130 Genetic Analyzer. The sequences were edited 
before searching the BLAST database of the National Center for Biotechnology 
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Information (NCBI) Genbank for sequence matches. These edits consisted of removing 










A total of 88 serum samples, from 30 counties within the state of Kentucky, were 
tested serologically for antibodies specific for the protozoan parasite, Trypanosoma cruzi. 
The geographic distribution of positive samples by county is depicted in Figure 3.1 and 
3.2. When analyzing the data that came with the T. cruzi positive serum samples, there 
were some similarities. Four male and five female canines were sero-positive with an age 
span ranging from 2.5 years to 8 years. Four of the positive samples were obtained from 
four-year-old canines and two positive samples were collected from eight-year-old 
canines. When analyzing the breeds of the canines that tested positive, the only similarity 
found was that two of the positive canines were coonhounds.  
The results of a recent collaboration with the Breathitt Veterinary Diagnostic Lab 
in Hopkinsville Kentucky are shown in Figure 3.2 (unpublished results). Canine samples 
from the Breathitt laboratory collaboration were obtained primarily from counties in 
central and western Kentucky whereas canine samples analyzed in the present study were 




Figure 3.1: Geographic distribution by county of T. cruzi positive canine samples (UK 




Figure 3.2: Geographic distribution by county of T. cruzi positive canine samples 






Figure 3.3: Positive T. cruzi Serological Dipsticks 
 
DNA isolation 
DNA was isolated from positive samples using a QIAamp DNA blood mini kit 
(Qiagen) according to the manufacturer’s instructions. DNA concentrations (See Figure 
3.4) were determined using a Nanodrop 2000 and samples were then frozen at -20C until 

























Figure 3.4: DNA concentrations for T. cruzi positive canine serum samples 
 
PCR and Agarose gel electrophoresis 
 DNA samples from sero-positive dogs were subjected to PCR using T. cruzi-
specific primers TCZ1 and TCZ2. Resulting products were then subjected to 
electrophoresis. Two of the nine canine DNA samples were found to be PCR positive. 
These canine samples were from Boyle and Grant County. 
 
DNA Sequencing 
The PCR products from two positive canine DNA samples were further subjected 
to DNA sequencing analysis. One of the two samples resulted in a DNA sequence that 
gave a positive match when blasted using the BLAST database of the National Center for 
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Biotechnology Information (NCBI) Genbank. The sequence showed 94% identity to the 












Figure 3.6: Comparing Sample 15 to CAN III satellite sequence 
 
The canine that yielded this confirmed DNA sequence was from Boyle County. It 
was a three-year-old, female, English bulldog. Although we did not perform strain 
identification of the positive sequence, its match to the CAN III satellite sequence 













Other Vector borne diseases:  
 Eighty-eight canine serum samples from 30 counties were tested for Ehrlichia 
canis/ewingii, Borrelia burgdorferi, Anaplasma phagocytophilum/platys, and Dirofilaria 
immitis using Snap 4DX Plus tests.  
Of the 88 samples, 6 tested positive for Borrelia burgdorferi, the causative agent 
of Lyme disease (Figure 3.7). The gender of the Lyme positive canines was split evenly 
with 50% being male and 50% being female. Three of the positive samples were from 
Fayette County which includes the city of Lexington, Kentucky’s second largest city. 
One other sample was from Jessamine, a county neighboring Fayette. 
Five of the 88 canine serum samples tested positive for Ehrlichia canis/ewingii, 
the causative agent of ehrlichiosis. (See Figure 3.8) None of the canines in this study 





County Breed Gender Age 
2 Laurel mountain kurr F 3 
13 Whitley fiest  F 3 








65 N/a n/a M 2.5 
83 Jessamine mixed breed M 8 






County Breed Gender Age 
2 Laurel mountain kurr F 3 
9 Marion coonhound M 5 
14 Breckinridge N/A F 6 
79 Washington lab F 3 
86 Russell Australian 
shepherd 
M 4 











 The results of this study confirm the presence of Trypanosoma cruzi infection in 
the domestic canine population of central and eastern Kentucky. Serological analysis of 
the serum samples, showed a sero-prevalence of 10.23% (9/88). Two of the nine canine 
samples were also found to be positive for T. cruzi by a highly sensitive PCR analysis. 
One positive sample was confirmed to be T. cruzi based upon a 94% DNA sequence 
identity to the satellite DNA sequence of the CAN III strain. The CAN III strain of T. 
cruzi is known to be Type IV strain based upon serotype analysis. In an earlier 
unpublished study conducted in collaboration with the Breathitt Veterinary Diagnostic 
Research Laboratory, a sero-prevalence of 12.5% was observed from the central and 
western half of the state. The overall sero-prevalence of Trypanosoma cruzi across the 
state of Kentucky may be as high as 12.9% (58/449). 
 There have been many studies performed across the southeastern United States 
that have documented the presence of T. cruzi infection in canine populations since 1972. 
The prevalence of infection reported in these studies ranged- from a low of 1% in a 
Virginia study, as reported by Rosypal et al. (2010), to as high as 22% in a Louisiana 
study (Nieto et al., 2009). It should be noted that the Nieto et al. study in 2009 consisted 
of only 50 dogs. The study performed by Rosypal et al. in 2010 had a sample size of 90 
canines. The most recent study reporting sero-prevalence of canine Chagas was 
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conducted with shelter populations in Texas (Tenney et al., 2014). The sero-prevalence 
reported in this study was 8.8% of 205 canines. 
When comparing the eastern (Figure 3.1) and western (Figure 3.2) halves of 
Kentucky to look for contradicting results, there were two counties that yielded  different 
results. Montgomery and Taylor counties both had sero-positive canine samples in the 
Breathitt collaboration, but yielded sero-negative samples in the UK collaboration. 
During the comparison; Jefferson, Mercer and Breckinridge County yielded exclusively 
sero-negative samples in both studies. Within this study, no statistical comparisons were 
performed between the two collaborations.  The purpose of the current study was strictly 
to investigate the prevalence of T. cruzi. 
In the present study, PCR was used to confirm any serological positives because 
the InBios assay is a serological test that strictly looks for antibodies to T. cruzi. The PCR 
analysis is more sensitive and actually confirms the presence of T. cruzi DNA in canine 
serum samples. It should be noted that none of the T. cruzi positive samples tested 
positive for any of the other vector-borne pathogens looked at in this study. The TCZ1 
and TCZ2 primers were used for the PCR analysis because these primers are specific for 
185 base pairs of the highly repetitive 195 base pair sequence also known as the CAN III 
satellite sequence (Moser et al. 1989). Due to the repetitiveness of CAN III Satellite 
sequence, it allows for a much larger amplification of the DNA than if the primers were 
only targeting a small portion of the T. cruzi genome. These primers are highly specific 
and only target this DNA sequence while not replicating other DNA sequences that may 
be present.  
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Within our study, there was a difference between the number of serological 
positives and those that were confirmed by PCR and then by DNA sequencing. This is 
probably because samples consisted primarily of serum and not whole blood. 
Consequently, the DNA yield was much smaller, which may have made it difficult to get 
sufficient quantities of parasite DNA to amplify. Another possible explanation is that the 
long-term storage of serum samples may have resulted in DNA degradation. By the time 
the serum samples arrived in our lab, it may have been six weeks or more since the 
samples were originally submitted to the diagnostic lab by veterinarians. One final 
possibility is that some of the dogs may have been exposed to T. cruzi but did not develop 
symptomatic Chagas disease. 
It should be noted that all canines in this study were cared for by veterinarians in 
central and eastern Kentucky. Most of the dogs in this study were likely to be on 
preventatives for heartworm, if they went to a veterinarian on a regular basis, which 
explains the lack of positive samples for the canine heartworm (Dirofilaria immitis). The 
prevalence of Lyme disease on the Snap 4DX Plus tests may also not be a completely 
accurate estimate of Lyme disease prevalence since the SNAP test is also an antibody 
test, and does not confirm the presence of Borrelia burgdorferi.  
Canine Chagas disease is currently not diagnosed by veterinarians in the state of 
Kentucky. This diagnosis may not be occurring because either veterinarians aren’t aware 
that the disease has reached Kentucky or because the majority of the canines are 
asymptomatic. If there are no apparent symptoms, then there is no reason for a 
veterinarian to submit blood work to the CDC or another diagnostic lab. The difficulty of 
diagnosis is further compounded by the lack of a clinical serological test for Chagas 
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disease to be used within veterinary clinics across the state. The InBios Canine Chagas 
Dipstick was only approved for use in research, and it is now no longer available for 
purchase due to the low demand. Finally, another reason for a lack of diagnosis is that 
necropsies are rarely performed on canines. A necropsy is the only way to absolutely 
confirm that a canine was infected by T. cruzi upon its death. Necropsies in the United 
States are very expensive and are not usually requested by an owner when their pet dies 
suddenly.  
In conclusion, the results of this study demonstrate that dogs are being exposed to 
Trypanosoma cruzi in Kentucky. Determining whether they are acquiring the actual 
disease or just being exposed will require further studies. Veterinarians within the region 
need to be notified that this parasitic disease is present in the state and that their patients 
are at possible risk of infection. Future studies should be performed on canines found 
within humane societies or shelters to survey canines that may not be actively cared for 
by veterinarians their entire lives. Another future study that should be pursued based 
upon the results of this study is to further investigate the higher prevalence of Lyme 
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